DL-Pyroglutamic acid
DL-Pyroglutamic acid (CAE) as an inactivator of hepatitis B surface, inactivates vaccinia virus, herpes simplex virus, and influenza virus except poliovirus. DL-Pyroglutamic acid is also a possible inhibitor of GABA transaminase, increases GABA amount with antiepileptic action[1][2].
Product Specifications
CAS Number
149-87-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
GABA Receptor; Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/dl-pyroglutamic-acid.html
Purity
99.21
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1NC(CC1)=O)O
Molecular Formula
C5H7NO3
Molecular Weight
129.11
Precautions
H302, H315, H319, H335
References & Citations
[1]Sugimoto Y, et al. N-alpha-Cocoyl-L-arginine ethyl ester, DL-pyroglutamic acid salt, as an inactivator of hepatitis B surface antigen. Antimicrob Agents Chemother. 1979 Sep;16 (3) :329-32.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1308111-01 0.02 mg (Yeast)
Recombinant Human Protein boule-like (BOLL)
Sign In for Pricing
View Details MBS1308111-02 0.1 mg (Yeast)
Recombinant Human Protein boule-like (BOLL)
Sign In for Pricing
View Details MBS1308111-03 1 mg (Yeast)
Recombinant Human Protein boule-like (BOLL)
Sign In for Pricing
View Details MBS1308111-04 5x 1 mg (Yeast)
Recombinant Human Protein boule-like (BOLL)
Sign In for Pricing
View Details 